The Early Events Determining SIV Rectal Transmission
决定 SIV 直肠传播的早期事件
基本信息
- 批准号:8119932
- 负责人:
- 金额:$ 37.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-15 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Although anal intercourse is a common mode of HIV-1 transmission, particularly for men who have sex with men, many fundamental and mechanistic questions remain. The long-term objective of this study is to understand the early events in HIV-1 rectal transmission and to gain new insights, which will potentially lead to new intervention strategies, including vaccines and topical microbicides optimized for rectal use. Studying HIV-1 vaginal transmission in the highly relevant SIV-rhesus macaque model has revealed important events critical for transmission, such as target cell availability, innate immune response, and inflammation at the portal of entry, all factors which play a key role in transmission. Because the anatomical/histological features and the physiological functions of vagina and cervix differ from the rectum, we hypothesize that the underlying mechanisms and timing of HIV-1 rectal transmission will significantly differ from those of vaginal-cervical transmission. Utilizing innovative approaches and an established conceptual framework from studies of vaginal transmission, we will test this hypothesis by investigating three specific aims: 1) determine the timing, location, spatial distribution and cell types of virus-infected cells at the portal of entry and in draining and distal lymphatic tissues; 2) determine relationships between virus and susceptible target cells (CD4+ T cells, macrophages, and dendritic cells) and between virus-infected cells and the mucosal innate immune response in the rectum shortly after intra-rectal SIV inoculation, thereby determining whether changes in target-cell availability play a critical role in local expansion and systemic spread of infection; and 3) determine the spatial relationships and ratio of virus-specific CD8+ T effector cells (E) and virus-infected-target cells (T) at the portal of entry and in other tissue compartments to extent of control of virus replication, using a novel procedure combining in-situ tetramers and in-situ hybridization The proposed research is significant as it is expected to reveal important mechanisms underlying rectal transmission and potentially provide guidance for designing anti-HIV-1 vaccines and topical microbicides.
虽然肛交是HIV-1传播的一种常见方式,特别是对男男性行为者而言,但仍存在许多基本的机制性问题。这项研究的长期目标是了解HIV-1直肠传播的早期事件,并获得新的见解,这将可能导致新的干预策略,包括针对直肠使用优化的疫苗和局部杀微生物剂。在高度相关的SIV-恒河猴模型中研究HIV-1阴道传播揭示了对传播至关重要的重要事件,例如靶细胞可用性,先天免疫反应和入口处的炎症,所有这些因素都在传播中起着关键作用。由于阴道和宫颈的解剖学/组织学特征和生理功能与直肠不同,我们假设HIV-1直肠传播的潜在机制和时间与阴道-宫颈传播的机制和时间显著不同。利用创新的方法和从阴道传播研究中建立的概念框架,我们将通过调查三个具体目标来验证这一假设:1)确定病毒感染细胞在入口和引流及远端淋巴组织中的时间、位置、空间分布和细胞类型; 2)确定病毒与易感靶细胞之间的关系(CD 4 + T细胞、巨噬细胞和树突状细胞)之间以及直肠内SIV接种后不久直肠中病毒感染的细胞和粘膜先天免疫应答之间的关系,从而确定靶细胞可用性的变化是否在感染的局部扩张和全身传播中发挥关键作用;和3)确定病毒特异性CD 8 + T效应细胞(E)和病毒感染的靶细胞(T)在进入口和其它组织区室中的空间关系和比例,以控制病毒复制的程度,使用结合原位四聚体和原位杂交的新方法所提出的研究是重要的,因为它有望揭示直肠传播的重要机制,并可能为设计抗HIV-1疫苗和局部杀微生物剂提供指导。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Qingsheng Li其他文献
Qingsheng Li的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Qingsheng Li', 18)}}的其他基金
Mechanisms of resistance to immune therapy in NSCLC
NSCLC 免疫治疗耐药机制
- 批准号:
10093111 - 财政年份:2020
- 资助金额:
$ 37.14万 - 项目类别:
Mechanisms of resistance to immune therapy in NSCLC
NSCLC 免疫治疗耐药机制
- 批准号:
10577776 - 财政年份:2020
- 资助金额:
$ 37.14万 - 项目类别:
Mechanisms of resistance to immune therapy in NSCLC
NSCLC 免疫治疗耐药机制
- 批准号:
10333209 - 财政年份:2020
- 资助金额:
$ 37.14万 - 项目类别:
Next Generation Broadly Neutralizing Antibodies to Clear HIV-1 Reservoir
下一代广泛中和抗体可清除 HIV-1 病毒库
- 批准号:
10515649 - 财政年份:2018
- 资助金额:
$ 37.14万 - 项目类别:
Next Generation Broadly Neutralizing Antibodies to Clear HIV-1 Reservoir
下一代广泛中和抗体可清除 HIV-1 病毒库
- 批准号:
10287487 - 财政年份:2018
- 资助金额:
$ 37.14万 - 项目类别:
Next Generation Broadly Neutralizing Antibodies to Clear HIV-1 Reservoir
下一代广泛中和抗体可清除 HIV-1 病毒库
- 批准号:
10054157 - 财政年份:2018
- 资助金额:
$ 37.14万 - 项目类别:
The Early Events Determining SIV Rectal Transmission
决定 SIV 直肠传播的早期事件
- 批准号:
8335607 - 财政年份:2010
- 资助金额:
$ 37.14万 - 项目类别:
The Early Events Determining SIV Rectal Transmission
决定 SIV 直肠传播的早期事件
- 批准号:
8310089 - 财政年份:2010
- 资助金额:
$ 37.14万 - 项目类别:
The Early Events Determining SIV Rectal Transmission
决定 SIV 直肠传播的早期事件
- 批准号:
8516028 - 财政年份:2010
- 资助金额:
$ 37.14万 - 项目类别:
The Early Events Determining SIV Rectal Transmission
决定 SIV 直肠传播的早期事件
- 批准号:
8066302 - 财政年份:2010
- 资助金额:
$ 37.14万 - 项目类别:
相似国自然基金
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
- 批准号:31272541
- 批准年份:2012
- 资助金额:82.0 万元
- 项目类别:面上项目
相似海外基金
Impacts of the migratory dendritic cells on tumor-specific T cell fate in the thymus
迁移树突状细胞对胸腺中肿瘤特异性 T 细胞命运的影响
- 批准号:
24K18461 - 财政年份:2024
- 资助金额:
$ 37.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CAREER: Understanding the Immunometabolism-Epigenetic Crosstalk in Dendritic Cells
职业:了解树突状细胞中的免疫代谢-表观遗传串扰
- 批准号:
2412256 - 财政年份:2023
- 资助金额:
$ 37.14万 - 项目类别:
Continuing Grant
Effector-triggered immunity against Legionella pneumophila in dendritic cells
树突状细胞中针对嗜肺军团菌的效应子触发免疫
- 批准号:
10753211 - 财政年份:2023
- 资助金额:
$ 37.14万 - 项目类别:
Unified mechanism elucidation of efficacy and side effects of JAK inhibition by targeting dendritic cells
通过靶向树突状细胞抑制 JAK 的功效和副作用的统一机制阐明
- 批准号:
23K06897 - 财政年份:2023
- 资助金额:
$ 37.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Evaluation of a therapeutic vaccination strategy with motif neoepitope peptide-pulsed autologous dendritic cells for non-small cell lung cancer patients harboring a charged HLA-B binding pocket.
使用基序新表位肽脉冲的自体树突状细胞对携带带电 HLA-B 结合袋的非小细胞肺癌患者的治疗性疫苗接种策略进行评估。
- 批准号:
10721983 - 财政年份:2023
- 资助金额:
$ 37.14万 - 项目类别:
Homeostatic maintenance and activation of dental pulp quiescent stem/progenitor cells regulated by dendritic cells and macrophages
树突状细胞和巨噬细胞调节的牙髓静止干/祖细胞的稳态维持和激活
- 批准号:
23H03078 - 财政年份:2023
- 资助金额:
$ 37.14万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a new cancer immunotherapy using the exosome derived from neoantigen pulsed mature dendritic cells
使用源自新抗原脉冲成熟树突状细胞的外泌体开发新的癌症免疫疗法
- 批准号:
23K08073 - 财政年份:2023
- 资助金额:
$ 37.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The research of targeting tumor-associated dendritic cells, a new therapy strategy by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses
靶向肿瘤相关树突状细胞的研究,树突状细胞介导肿瘤相关抗原的摄取和抗肿瘤反应的新治疗策略
- 批准号:
23K14668 - 财政年份:2023
- 资助金额:
$ 37.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The role of plasmacytoid dendritic cells in corneal immunity
浆细胞样树突状细胞在角膜免疫中的作用
- 批准号:
10640026 - 财政年份:2023
- 资助金额:
$ 37.14万 - 项目类别:
Ontogeny and Function of Early-Life Pulmonary Dendritic Cells
早期肺树突状细胞的个体发育和功能
- 批准号:
10667996 - 财政年份:2023
- 资助金额:
$ 37.14万 - 项目类别:














{{item.name}}会员




